Validation of interventional fiber optic spectroscopy with MR Spectroscopy, MAS-NMR spectroscopy, high-performance thin-layer chromatography, and histopathology for accurate hepatic fat quantification

Investigative Radiology

Volumn 47, Issue 4, 2012, Pages 209-216

  Nachabé, Rami ^a   Van Der Hoorn, José W A ^b   Van De Molengraaf, Roland ^a   Lamerichs, Rolf ^a   Pikkemaat, Jeroen ^c   Sio, Charles F ^a   Hendriks, Benno H W ^a   Sterenborg, Henricus J C M ^c  

^a PHILIPS RESEARCH LABORATORIES   (Netherlands)

^b TNO   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

liver fat content; magnetic resonance image; magnetic resonance spectroscopy; near infrared spectroscopy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FIBER OPTIC SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; INTERMETHOD COMPARISON; LIPID DIET; MAGIC ANGLE SPINNING NUCLEAR MAGNETIC RESONANCE; MEASUREMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SPECTROSCOPY;

EID: 84858706251     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318237527b     Document Type: Article

References (35)

1. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917-923. (Pubitemid 36397405)
2. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological system for nonalcoholic fatty liver disease. Hepatology. 2005; 41:1313-1321. (Pubitemid 40770284)
3. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005;173:734-735.
4. Mehta SR, Thomas EL, Bell JD, et al. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008;14:3476-3483.
5. Fischer MA, Gnannt R, Raptis D, et al. Quantification of liver fat in the presence of iron and iodine: an ex-vivo dual-energy CT study. Invest Radiol. 2011;46:351-358.
6. Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189-194. (Pubitemid 14043406)
7. Fabbrini E, Conte C, Magkos F. Methods for assessing intrahepatic fat content and steatosis. Curr Opin Clin Nutr Metab Care. 2009;12:474-481.
8. Springer F, Machann J, Claussen CD, et al. Liver fat content determined by magnetic resonance imaging and spectroscopy. 2010;16:1560-1566.
9. Kühn JP, Evert M, Friedrich N, et al. Noninvasive quantification of hepatic fat content using three-echo Dixon magnetic resonance imaging with correction for T2* relaxation effects. Invest Radiol. 2011;46:783-789.
10. Reeder SB, Robson PM, Yu H, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging. 2009;29:1332-1339.
11. Bigio IJ, Bown SG, Briggs G, et al. Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results. J Biomed Opt. 2000;5:221-228.
12. Van Veen RL, Amelink A, Menke-Pluymers M, et al. Optical biopsy of breast tissue using differential path-length spectroscopy. Phys Med Biol. 2005;50: 2573-2581. (Pubitemid 40770640)
13. Yu B, Burnside ES, Sisney GA, et al. Feasibility of near-infrared diffuse optical spectroscopy on patients undergoing image guided core-needle biopsy. Opt Express. 2007;15:7335-7350. (Pubitemid 46906946)
14. Nachabé R, Hendriks BH, Desjardins AE, et al. Estimation of lipid and water concentrations in scattering media with diffuse optical spectroscopy from 900 to 1600 nm. J Biomed Opt. 2010;15:037015.
15. Nachabé R, Hendriks BH, Van Der Voort M, et al. Estimation of biological chromophores using diffuse optical spectroscopy: benefit of extending the UV-VIS wavelength range to include 1000 to 1600 nm. Biomed Opt Express. 2010;1:1432-1442.
16. Nachabé R, Evers DJ, Hendriks BH, et al. Effect of bile absorption coefficients on the estimation of liver tissue optical properties and related implications in discriminating healthy and tumorous samples. Biomed Opt Express. 2011;2:600-614.
17. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2002;17:186-190.
18. Bollard ME, Garrod S, Holmes E, et al. High-resolution 1H and 1H-13C magic angle spinning NMR spectroscopy of rat liver. Magn Reson Med. 2000;44:201-207. (Pubitemid 30614778)
19. Garrod S, Humpher E, Connor SC, et al. High-resolution 1H NMR and magic angle spinning NMR spectroscopic investigation of the biochemical effects of 2-bromoethanamine in intact renal and hepatic tissue. Magn Reson Med. 2001;45:781-790. (Pubitemid 32402020)
20. Martínez-Granados B, Monleón D, Martínez-Bisbal MC, et al. Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H NMR spectroscopy. NMR Biomed. 2006;19:90-100. (Pubitemid 43250794)
21. Waters NJ, Garrod S, Farrant RD, et al. High-resolution magic angle spinning 1H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal Biochem. 2000;282:16-23. (Pubitemid 30409419)
22. Waters NJ, Holmes E, Waterfield CJ, et al. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alphanaphthylisothiocyanate. Biochem Pharmacol. 2002;64:67-77. (Pubitemid 34775177)
23. Westerterp M, Van der Hoogt CC, De Haan W, et al. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice. Arterioscler Thromb Vasc Biol. 2006;26:2552-2559. (Pubitemid 44607480)
24. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 1987;508:333-348.
25. Naressi A, Couturien C, Devos JM, et al. Java-based graphical user interface for the MRUI quantitation package. Magma. 2001;12:141-152. (Pubitemid 32510133)
26. De Bazelaire CM, Duhamel GD, Rofsky NM, et al. MR imaging relaxation times of abdominal and pelvic tissue measured in vivo at 2.0T: preliminary results. Radiology. 2004;230:652-659. (Pubitemid 38252858)
27. Guiu B, Loffroy R, Petit JM, et al. Mapping of liver fat with triple-echo gradient echo imaging: validation against 3T proton MR spectroscopy. Eur Radiol. 2009;19:1789-1793.
28. Van Ginneken V, Verhey E, Poelmann R, et al. Metabolics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis. Biochim Biophys Acta. 2007;1771:1637-1670.
29. Jarque CM, Bera AK. A test for normality of observations and regression residuals. Inter Stat Rev. 1987;55:163-172.
30. Bernard CP, Liney GP, Manton DJ, et al. Comparison of fat quantification methods: a phantom study at 3. 0T.J. Magn Reson Imaging. 2008;27:192-197.
31. Tromberg BJ, Shah N, Lanning R, et al. Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia. 2000;2: 26-40. (Pubitemid 30123178)
32. Spinelli L, Torricelli A, Pifferi A, et al. Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography. J Biomed Opt. 2004;9:1137-1142. (Pubitemid 40168127)
33. Kitai T, Beauvoit B, Chance B. Optical determination of fatty change of the graft liver with near-infrared time-resolved spectroscopy. Transplantation. 1996;62:642-647. (Pubitemid 26313909)
34. Nachabé R, Evers DJ, Hendriks BH, et al. Diagnosis of breast cancer using diffuse optical spectroscopy from 500 to 1600 nm: comparison of classification methods. J Biomed Opt. 2011;16:087010.
35. Fischer MA, Nanz D, Reiner CS, et al. Diagnostic performance and accuracy of 3-D spoiled Gradient-dual-Echo MRI with water-and fat-signal separation in liver-fat quantification: comparison to liver biopsy. Invest Radiol. 2010; 45:465-470.